References
- Attias J., Bresloff I., Reshef I., Horowitz G., Furman V. Evaluating noise induced hearing loss with distortion product otoacoustic emissions. Br J Audiol 1998; 32: 39–49
- Brock P.R., Bellman S.C., Yeomans E.C., Pinkerton C.R., Pritchard J. Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol 1991; 19: 295–300
- Fausti S.A., Larson V.D., Noffsinger D., Wilson R.H., Philips D.S., et al. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear 1994; 15: 232–239
- Freilich R.J., Kraus D.H., Budnick A.S., Bayer L.A., Finlay J.L. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Pediatr Oncol 1996; 26: 95–100
- Littman T.A., Magruder A., Strother D.R. Monitoring and predicting ototoxic damage using distortion-product otoacoustic emissions: pediatric case study. J Am Acad Audiol 1998; 9: 257–262
- Parsons S.K., Neault M.W., Lehmann L.E., Brennan L.L., Eickhoff C.E., et al. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant 1998; 22: 669–674
- Ress B.D., Sridhar K.S., Balkany T.J., Waxman G.M., Stagner B.B., et al. Effects of cis-platinum chemotherapy on otoacoustic emissions: The development of an objective screening protocol. Third place—Resident Clinical Science Award 1998. Otolaryngol Head Neck Surg 1999; 21: 693–701
- Sakamoto M., Kaga K., Kamio T. Extended high-frequency ototoxicity induced by the first administration of cisplatin. Otolaryngol Head and Neck Surg 2000; 122: 828–833
- Schweitzer V.G. Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 1993; 26: 759–789
- Simon T., Hero B., Dupuis W., Selle B., Berthold F. The incidence of hearing impairment after successful treatment of neuroblastoma. Klin Padiatr 2002; 214: 149–152
- Stavroulaki P., Apostolopoulos N., Segas J., Tsakanikos M., Adamopoulos G. Evoked otoacoustic emissions–an approach for monitoring cisplatin induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 2001; 59: 47–57
- Stern J.W., Bunin N. Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors. Med Pediatr Oncol 2002; 39: 163–167
- Vinck B.M., De Vel E., Xu Z.M., Van Cauwenberge P.B. Distortion product otoacoustic emissions: a normative study. Audiology 1996; 35: 231–245
- Watanabe K.C., Jinnouchi K., Hess A., Michel O., Baba S., et al. Carboplatin induces less apoptosis in the cochlea of guinea pigs than cisplatin. Chemotherapy 2002; 48: 82–87
- Zorowka P.G., Schmitt H.J., Gutjahr P. Evoked otoacoustic emissions and pure-tone threshold audiometry in patients receiving cisplatinum therapy. Int J Pediatr Otorhinolaryngol 1993; 25: 73–80